AR and prostate cancer: Lastly, the stapledpeptide used in this study, as well as other small molecules capable ofdisrupting the AR/FlnA interaction, might represent a promising approach tospecifically modulate AR functions in stromal tissue and rescue hormoneproliferative responsiveness in human prostate cancers.